Silverarc Capital Management as of Dec. 31, 2021
Portfolio Holdings for Silverarc Capital Management
Silverarc Capital Management holds 70 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr Ser Tr S&p Biotech Call Option (XBI) | 9.1 | $22M | 200k | 111.96 | |
ImmunoGen | 4.6 | $11M | 1.5M | 7.42 | |
Biohaven Pharmaceutical Holding | 4.5 | $11M | 80k | 137.81 | |
Intra Cellular Therapies (ITCI) | 4.1 | $10M | 195k | 52.34 | |
Merus N V (MRUS) | 4.1 | $10M | 320k | 31.80 | |
Veracyte (VCYT) | 3.7 | $9.1M | 221k | 41.20 | |
Mirati Therapeutics | 3.6 | $8.9M | 61k | 146.68 | |
Bellus Health Com New | 3.6 | $8.9M | 1.1M | 8.05 | |
Cogent Biosciences (COGT) | 3.0 | $7.3M | 851k | 8.58 | |
Galapagos Nv Spon Adr (GLPG) | 2.9 | $7.1M | 129k | 55.13 | |
Cerus Corporation (CERS) | 2.9 | $7.1M | 1.0M | 6.81 | |
Horizon Therapeutics Pub L SHS | 2.7 | $6.6M | 62k | 107.76 | |
Iteos Therapeutics (ITOS) | 2.6 | $6.4M | 138k | 46.56 | |
Apollo Endosurgery | 2.5 | $6.2M | 740k | 8.43 | |
Research Alliance Corp Ii Com Cl A | 2.2 | $5.4M | 557k | 9.72 | |
Immatics SHS (IMTX) | 2.1 | $5.3M | 391k | 13.44 | |
Lucira Health | 1.8 | $4.4M | 515k | 8.61 | |
Sierra Oncology Com New | 1.7 | $4.2M | 192k | 21.74 | |
Aclaris Therapeutics (ACRS) | 1.7 | $4.2M | 286k | 14.54 | |
Amryt Pharma Sponsored Ads | 1.5 | $3.8M | 350k | 10.80 | |
Cti Biopharma | 1.5 | $3.7M | 1.5M | 2.48 | |
Leap Therapeutics | 1.3 | $3.3M | 1.0M | 3.24 | |
Krystal Biotech (KRYS) | 1.3 | $3.3M | 47k | 69.96 | |
Morphic Hldg (MORF) | 1.3 | $3.2M | 67k | 47.38 | |
Crinetics Pharmaceuticals In (CRNX) | 1.3 | $3.2M | 112k | 28.41 | |
United Therapeutics Corporation (UTHR) | 1.3 | $3.1M | 15k | 216.07 | |
Xenon Pharmaceuticals (XENE) | 1.3 | $3.1M | 100k | 31.24 | |
Halozyme Therapeutics (HALO) | 1.2 | $2.9M | 71k | 40.21 | |
Insmed Com Par $.01 (INSM) | 1.1 | $2.7M | 101k | 27.24 | |
Seres Therapeutics (MCRB) | 1.1 | $2.7M | 321k | 8.33 | |
Cytokinetics Com New (CYTK) | 1.1 | $2.7M | 58k | 45.57 | |
Otonomy | 1.0 | $2.5M | 1.2M | 2.08 | |
Miragen Therapeutics (VRDN) | 1.0 | $2.4M | 124k | 19.77 | |
Viewray (VRAYQ) | 1.0 | $2.4M | 428k | 5.51 | |
Aurinia Pharmaceuticals (AUPH) | 0.9 | $2.3M | 100k | 22.87 | |
Eyepoint Pharmaceuticals Com New (EYPT) | 0.9 | $2.2M | 182k | 12.24 | |
Syndax Pharmaceuticals (SNDX) | 0.9 | $2.2M | 100k | 21.89 | |
Stereotaxis Com New (STXS) | 0.9 | $2.1M | 344k | 6.20 | |
Jounce Therapeutics | 0.8 | $2.1M | 246k | 8.35 | |
Cyclacel Pharmaceuticals | 0.7 | $1.8M | 459k | 3.89 | |
Celldex Therapeutics Com New (CLDX) | 0.7 | $1.7M | 45k | 38.64 | |
Aslan Pharmaceuticals Ads | 0.7 | $1.7M | 1.5M | 1.12 | |
Seagen | 0.7 | $1.7M | 11k | 154.59 | |
Bridgebio Pharma (BBIO) | 0.7 | $1.7M | 100k | 16.68 | |
Poseida Therapeutics I (PSTX) | 0.6 | $1.6M | 235k | 6.81 | |
Deciphera Pharmaceuticals (DCPH) | 0.6 | $1.6M | 161k | 9.77 | |
Benitec Biopharma | 0.6 | $1.5M | 588k | 2.62 | |
Biogen Idec (BIIB) | 0.6 | $1.4M | 5.7k | 239.90 | |
Eloxx Pharmaceuticals | 0.6 | $1.4M | 1.9M | 0.71 | |
Helix Acquisition Corp Com Cl A | 0.5 | $1.3M | 132k | 9.89 | |
Medicus Sciences Acquisition Cl A Shs | 0.5 | $1.2M | 129k | 9.69 | |
Polypid SHS | 0.5 | $1.2M | 216k | 5.74 | |
Social Cap Suvretta Hlds Crp Class A Ord Shs | 0.5 | $1.2M | 124k | 9.93 | |
Social Cap Suvretta Hld Crpi Class A Ord Shs | 0.5 | $1.2M | 124k | 9.90 | |
Social Cap Suvretta Hlds Crp Class A Ord Shs | 0.5 | $1.2M | 124k | 9.89 | |
Social Cap Suvretta Hlds Cp Class A Ord Shs | 0.5 | $1.2M | 124k | 9.82 | |
Nextcure (NXTC) | 0.5 | $1.2M | 193k | 6.00 | |
Point Biopharma Global | 0.5 | $1.1M | 205k | 5.60 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.4 | $1.1M | 5.0k | 219.60 | |
Inhibrx (INBX) | 0.4 | $1.1M | 25k | 43.66 | |
Curis Com New Call Option | 0.4 | $952k | 200k | 4.76 | |
Compugen Ord (CGEN) | 0.4 | $944k | 220k | 4.30 | |
Kura Oncology (KURA) | 0.4 | $935k | 67k | 13.99 | |
Innate Pharma S A Sponsored Ads (IPHA) | 0.3 | $839k | 184k | 4.56 | |
Vistagen Therapeutics Com New | 0.3 | $827k | 424k | 1.95 | |
Evogene SHS (EVGN) | 0.2 | $481k | 293k | 1.64 | |
Mereo Biopharma Group Ads (MREO) | 0.2 | $373k | 233k | 1.60 | |
Calithera Biosciences | 0.1 | $146k | 220k | 0.66 | |
Renovacor *w Exp 99/99/999 | 0.0 | $60k | 105k | 0.57 | |
Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $36k | 50k | 0.72 |